Ampio pharmaceuticals presents corporate overview at h.c. wainwright bioconnect conference

Englewood, colo., jan. 6, 2022 /prnewswire/ -- ampio pharmaceuticals, inc. (nyse: ampe), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced that it will present at the h.c.
AMPE Ratings Summary
AMPE Quant Ranking